Deutsche Bank
BRLI

Deutsche Bank’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Deutsche Bank’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-154,820
Closed -$6.38M – 5570
2015
Q2 		$6.38M Buy
154,820
+110,552
+250% +$3.96M ﹤0.01% 1637
2015
Q1 		$1.56M Sell
44,268
-6,898
-13% -$233K ﹤0.01% 2615
2014
Q4 		$1.64M Buy
51,166
+17,857
+54% +$516K ﹤0.01% 2825
2014
Q3 		$934K Buy
33,309
+14,927
+81% +$455K ﹤0.01% 3077
2014
Q2 		$555K Buy
18,382
+426
+2% +$11.8K ﹤0.01% 3385
2014
Q1 		$496K Buy
17,956
+4,776
+36% +$125K ﹤0.01% 3339
2013
Q4 		$335K Sell
13,180
-23,510
-64% -$725K ﹤0.01% 3373
2013
Q3 		$1.09M Buy
36,690
+13,352
+57% +$371K ﹤0.01% 2911
2013
Q2 		$669K Buy
+23,338
New +$643K ﹤0.01% 2982

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Deutsche Bank's BRLI Position: Q3 2015 in Review

Deutsche Bank sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 154,820 shares — an estimated $6.38M sold.

Deutsche Bank first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $6.38M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Deutsche Bank reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Deutsche Bank sold 154,820 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $6.38M.
  • Deutsche Bank first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Deutsche Bank's BIO-REFERENCE LABS INC-NEW- position peaked at $6.38M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Deutsche Bank's 13F filing for Q3 2015, filed 17 Nov 2015.